Pharmaron Placement - Strong Track Record
Joint Global coordinators aim to raise around US$125m via selling shares in Pharmaron in order to aid certain convertible bond investors to hedge...
WuXi AppTec (2359.HK) - The Certainties and the Uncertainties
As the benchmark company in China CRO/CDMO industry, WuXi AppTec is always the focus of investors. This insight mainly analyzed the certainties and...
Pre-IPO Shanghai Haoyuan Chemexpress - A New CRO/CDMO with Continued High Growth Potential
As CRO/CDMO continues to be a hot sector for investors and have outstanding performance, the new pre-IPO company Haoyuan Chemexpress with high...
Novotech Pre-IPO: Biotech Focused CRO at Hefty Pre-IPO Valuation
Novotech has an interesting value proposition as a biotech focused CRO in the APAC region. The company has a decent growth in the past but we think...
Smartkarma Originals